What Are Beta-Blockers?

Beta-blockers (beta-adrenergic antagonists) slow the heart rate and reduce the heart's workload by blocking the effects of adrenaline. They are cornerstones of treatment for high blood pressure, heart failure, and arrhythmias.

Mechanism

Competitively block beta-1 (cardiac) and/or beta-2 (pulmonary/vascular) adrenergic receptors, reducing heart rate, myocardial contractility, and blood pressure.

Common Uses

Hypertension, heart failure, atrial fibrillation, post-MI cardioprotection, angina, essential tremor, migraine prophylaxis, performance anxiety.

Key Risks

Bradycardia, fatigue, bronchoconstriction (avoid in asthma), masking of hypoglycemia, peripheral coldness, rebound hypertension if stopped abruptly.

Examples

Metoprolol (Lopressor, Toprol XL), carvedilol (Coreg), atenolol, propranolol (Inderal), bisoprolol.

How Beta-Blockers Work

The sympathetic nervous system uses epinephrine (adrenaline) and norepinephrine to stimulate beta-adrenergic receptors throughout the body. Beta-1 receptors are found primarily in the heart; stimulation increases heart rate and the force of cardiac contractions. Beta-2 receptors are found in the lungs, blood vessels, and other tissues; stimulation causes bronchodilation and vasodilation.

Beta-blockers compete with these catecholamines for receptor binding. By occupying beta-1 receptors, they slow the heart rate (negative chronotropy), reduce the force of contraction (negative inotropy), and lower cardiac output — all of which reduce blood pressure and myocardial oxygen demand. This makes them especially valuable after heart attacks and in heart failure, where a chronically overworked heart benefits from a reduced workload.

Cardioselective beta-blockers (metoprolol, atenolol, bisoprolol) primarily target beta-1 receptors and have less effect on lung beta-2 receptors, making them safer in patients with mild asthma or COPD, though not entirely free of pulmonary risk. Non-selective beta-blockers (propranolol, carvedilol) block both beta-1 and beta-2 receptors. Carvedilol also blocks alpha-1 receptors, providing additional vasodilation.

Drugs in This Class

Common Side Effects Across the Class

Fatigue and reduced exercise tolerance

Slow heart rate (bradycardia)

Cold hands and feet

Dizziness (especially on standing)

Depression or mood changes

Sleep disturbances, vivid dreams

Erectile dysfunction

Worsening of bronchospasm in asthma

Important Interactions & Warnings

Calcium channel blockers (verapamil, diltiazem) — Combining with non-dihydropyridine CCBs can cause dangerous bradycardia and heart block. This combination should generally be avoided without close cardiac monitoring.
Insulin and oral antidiabetics — Beta-blockers can mask the usual warning signs of hypoglycemia (tremor, palpitations, anxiety), making it harder to recognize low blood sugar. Sweating is usually unmasked. Diabetic patients require closer glucose monitoring.
NSAIDs — Can blunt the blood pressure-lowering effect of beta-blockers. Use with caution in hypertensive patients.
Asthma and COPD — Beta-2 blockade can cause bronchoconstriction. Beta-blockers are generally contraindicated in severe asthma. If a beta-blocker is absolutely necessary, a cardioselective agent at the lowest effective amount is preferred.
Do not stop abruptly — Sudden discontinuation can cause rebound hypertension, worsening angina, or even myocardial infarction. Always taper under medical supervision.

Frequently Asked Questions

What is the difference between metoprolol and carvedilol?

Metoprolol is a cardioselective beta-1 blocker, primarily slowing the heart with less effect on the lungs. Carvedilol is a non-selective beta-blocker that also blocks alpha-1 receptors, adding vasodilation. Carvedilol lowers blood pressure more robustly and is preferred in heart failure with reduced ejection fraction. Metoprolol succinate (extended-release) is also indicated for heart failure and is often better tolerated in patients with pulmonary conditions.

Can beta-blockers be used for anxiety?

Propranolol is commonly used off-label for situational (performance) anxiety — such as public speaking or stage fright. It reduces physical symptoms like tremor, palpitations, and sweating without causing sedation. It is not approved or typically used for generalized anxiety disorder, where SSRIs or SNRIs are preferred long-term treatments.

Why must beta-blockers not be stopped suddenly?

Long-term beta-blocker use causes the heart to upregulate (increase the number of) beta-adrenergic receptors. If the drug is stopped abruptly, these excess receptors are suddenly exposed to circulating adrenaline, causing rebound hypertension, rapid heart rate, and — in patients with coronary artery disease — a risk of unstable angina or heart attack. A gradual taper over 1–2 weeks avoids this rebound effect.

Are beta-blockers first-line for hypertension?

Guidelines have shifted in recent years. Beta-blockers are no longer considered first-line for uncomplicated hypertension in most major guidelines, which favor ACE inhibitors, ARBs, calcium channel blockers, or thiazide diuretics. However, beta-blockers remain first-line when hypertension coexists with heart failure, post-MI, arrhythmia, or angina — conditions where their additional cardiac benefits are well established.